A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.
by
Martin Scharf,
Milton Erman,
Russell Rosenberg,
David Seiden,
W Vaughn McCall,
David Amato,
Thomas C Wessel
Related research
-
Göran Hajak, Jan Hedner, Mirjam Eglin, Henrik Loft, Signe I Stórustovu, Simone Lütolf, in Sleep Medicine (2009)OBJECTIVES: To evaluate the efficacy and safety profile of gaboxadol, a selective extrasynaptic GABA(A) agonist (SEGA) previously in development for the treatment of insomnia. METHODS: This was a randomised, double-blind, placebo-controlled,…Save reference to library · Related research 3 readers
-
W Vaughn McCall, Milton Erman, Andrew D Krystal, Russell Rosenberg, Martin Scharf, Gary K Zammit, in Current Medical Research And Opinion (2006)OBJECTIVE: To evaluate the safety and efficacy of eszopiclone 2 mg in elderly patients (aged 64-86 years) with chronic insomnia. METHODS: This was a randomized, double-blind, placebo-controlled 2-week study. Patients meeting DSM-IV criteria for…Save reference to library · Related research 3 readers
-
Gary K Zammit, Louis J McNabb, Judy Caron, David A Amato, Thomas Roth in Current Medical Research And Opinion (2004)OBJECTIVE: Eszopiclone is a new, single-isomer, non-benzodiazepine, cyclopyrrolone agent under investigation for the treatment of insomnia. The present study was a randomized, double-blind, multicenter, placebo-controlled trial conducted to assess…Save reference to library · Related research 4 readers
-
Thomas Roth, James K Walsh, Andrew Krystal, Thomas Wessel, Timothy A Roehrs in Sleep Medicine (2005)BACKGROUND AND PURPOSE: A double-blind placebo-controlled study of eszopiclone found significant, sustained improvement in sleep and daytime function. The 6-month open-label extension phase is described herein. PATIENTS AND METHODS: Adults (21-64)…Save reference to library · Related research 4 readers
-
Martin Scharf, Roberta Rogowski, Steven Hull, Martin Cohn, David Mayleben, Neil Feldman, et al. in J Clin Psychiatry (2008)OBJECTIVES: Evaluate efficacy and safety of the histamine-H(1) antagonist doxepin at doses of 1 mg, 3 mg, and 6 mg in elderly adults with primary insomnia. DESIGN: A randomized, double-blind, placebo-controlled, crossover design was used in this…Save reference to library · Related research 3 readers
-
Milton K Erman, Gary Zammit, Robert Rubens, Kendyl Schaefer, Thomas Wessel, David Amato, et al. in Journal of clinical sleep medicine JCSM official publication of the American Academy of Sleep Medicine (2008)STUDY OBJECTIVES: To evaluate the polysomnographic efficacy and the safety of a range of doses of eszopiclone relative to placebo in patients with primary insomnia. Zolpidem 10 mg was included as an active control. METHODS: This multicenter,…Save reference to library · Related research 5 readers
-
Russell Rosenberg, Judy Caron, Thomas Roth, David Amato in Sleep Medicine (2005)BACKGROUND AND PURPOSE: This randomized, double-blind, placebo-controlled study assessed the efficacy and safety of eszopiclone, a non-benzodiazepine hypnotic agent, in healthy adults using the first-night effect model of transient insomnia.…Save reference to library · Related research 2 readers
-
R Bruce Lydiard, D Alan Lankford, David J Seiden, Rick Landin, Robert Farber, James K Walsh in Journal of clinical sleep medicine JCSM official publication of the American Academy of Sleep Medicine (2006)STUDY OBJECTIVE: Indiplon is a nonbenzodiazepine GABA potentiator, which exhibits pharmacologic selectivity for GABA(A) receptors containing the alpha1 subunit. The aim of the present study was to evaluate the efficacy and safety of a 15-mg nightly…Save reference to library · Related research 1 reader
-
J E Dos Santos, A A Loures-Vale, J P Novazzi, L M Rabelo, T L Martinez in Arquivos Brasileiros de Cardiologia (1993)PURPOSE: To evaluate the clinical efficacy of etofibrate in primary hyperlipidemia in patients from clinical centers representative of all main Brazilian cities. METHODS: One thousand, nine hundred and fourty three hyperlipidemic patients were…Save reference to library · Related research 1 reader
-
James K Walsh, Christina Soubrane, Thomas Roth in The American journal of geriatric psychiatry official journal of the American Association for Geriatric Psychiatry (2008)OBJECTIVES: To evaluate the clinical efficacy and safety of zolpidem extended release for the treatment of primary insomnia in elderly patients. METHODS: A randomized, double-blind, placebo-controlled, parallel-group clinical trial was conducted. A…Save reference to library · Related research 4 readers
Readership Statistics
Readership statistics are being calculated.
Sign up today - FREE
Mendeley saves you time finding and organizing research. Learn more
- All your research in one place
- Add and import papers easily
- Access it anywhere, anytime